Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Artemether (40mg) + Lumefantrine (240mg) Tablet
Therapeutic Category
Anti-Inflammatories, Antipyretics, Anti Malarial
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*1*6
Price
₹159/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Arteslide L 40 Tablet is a fixed-dose combination of Artemether and Lumefantrine, widely recognized for its effectiveness in treating uncomplicated Plasmodium falciparum malaria. Artemether, a derivative of artemisinin, rapidly targets the malaria parasite by interfering with its ability to grow and reproduce. Lumefantrine, on the other hand, has a longer duration of action and works synergistically with Artemether to ensure the complete elimination of the parasite from the bloodstream.
This combination therapy is particularly advantageous due to its dual mechanism of action, reducing the risk of resistance development. Arteslide L 40 Tablet offers a highly effective treatment for patients in malaria-endemic regions, ensuring rapid relief from symptoms such as fever, chills, and body aches while preventing disease progression.
The well-balanced dose of 40mg Artemether and 240mg Lumefantrine is specifically designed to cater to adult patients and pediatric populations as prescribed by healthcare providers. Arteslide L 40 Tablet is a key therapy in antimalarial treatments, recognized for its excellent efficacy and minimal risk of relapse when the complete course is followed.
Possible side effects include headache, dizziness, abdominal pain, nausea, vomiting, or fatigue. Rarely, it may cause allergic reactions or changes in heart rhythm.
Arteslide L 40 Tablet is indicated for the treatment of uncomplicated Plasmodium falciparum malaria.
Take the full prescribed course to ensure the complete eradication of malaria. This medication should only be used under the guidance of a healthcare professional.
Store at a temperature below 30°C, away from direct sunlight and moisture. Keep out of reach of children.
Composition : Artemether (20mg) + Lumefantrine (120mg) Tablet
Composition : Artemether (80mg) + Lumefantrine (480mg) Tablet
Composition : Azithromycin (100mg) Tablet
Composition : Azithromycin (250mg) Tablet
Composition : Azithromycin (500mg) Tablet
Composition : Azithromycin (500mg) + Lactic acid bacillus (60Million spores) Tablet
Composition : Cefixime (100mg)
Composition : Cefixime (200mg) + Lactobacillus (2.5Billion Spores)
Composition : Cefixime (400mg)
Composition : Cefuroxime (250mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This anti-malarial combination tablet has strong demand in the infectious disease and tropical healthcare segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on anti-infective and malaria care portfolios.
Medical distributors and agencies can benefit from consistent demand for treatment and management of malaria and related parasitic infections, especially in malaria-prone regions. Artemether works rapidly to reduce malaria parasites in the bloodstream, while Lumefantrine helps eliminate remaining parasites and prevent recurrence, strengthening a reliable anti-malarial product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this anti-malarial combination tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong demand in anti-malarial therapy, institutional and regional healthcare supply opportunities, reliable supply chain support, and good margins when partnering for this anti-infective product.
Medical distributors, stockists, and wholesalers interested in this anti-malarial combination tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.